跳至主要内容
临床试验/NCT02011893
NCT02011893已完成不适用

Success Using Neuromodulation With BURST (SUNBURST™) Study

Abbott Medical Devices20 个研究点 分布在 1 个国家目标入组 173 人开始时间: 2013年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
173
试验地点
20
主要终点
Visual Analog Scale (VAS) Pain Diary Scores for Average Overall Pain

研究概览

简要总结

The purpose of the study is to demonstrate the safety and efficacy of the Prodigy system for the treatment of chronic intractable pain of the trunk and/or limbs.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Subject is 22 years of age or older
  • •Subject has chronic intractable pain of the trunk and/or limbs
  • •Subject has a average score of 60 or higher for average daily overall pain on the Visual Analog Scale (VAS) 7 day pain diary
  • •Subject has attempted "best" medical therapy and has tried and failed at least three documented medically supervised treatments (including, but not limited to physical therapy, acupuncture, etc.) and has failed medication treatment from at least two different classes
  • •Subject's pain-related medication regimen is stable 4 weeks prior to the baseline evaluation
  • •Subject agrees not to add or increase pain-related medication from activation through the 24 week follow-up visit

排除标准

  • •Subject is currently participating in a clinical investigation that includes an active treatment arm
  • •Subject has been implanted with a previous neurostimulation system or participated in a trial period for a neurostimulation system
  • •Subject's overall Beck Depression Inventory II Score is >24 or has a score of 3 on question 9 relating to suicidal thoughts or wishes at the screening visit
  • •Subject has an infusion pump or any implantable neurostimulator device
  • •Subjects with concurrent clinically significant or disabling chronic pain problem that requires additional treatment
  • •Subject has an existing medical condition that is likely to require repetitive Magnetic Resonance Imaging (MRI) evaluation in the future (i.e. epilepsy, stroke, multiple sclerosis, acoustic neuroma, tumor)
  • •Subject has an existing medical condition that is likely to require the use of diathermy in the future
  • •Subject's pain originates from peripheral vascular disease
  • •Subject is immunocompromised
  • •Subject has documented history of allergic response to titanium or silicone
  • •Subject has a documented history of substance abuse (narcotics, alcohol, etc.) or substance dependency in the 6 months prior to baseline data collection
  • •Female candidates of child bearing potential that are pregnant (confirmed by positive urine/blood pregnancy test)

研究组 & 干预措施

Tonic Stimulation

Active Comparator

Tonic Stimulation using the Prodigy system

干预措施: Tonic Stimulation (Device)

Burst Stimulation

Experimental

Burst Stimulation using the Prodigy system

干预措施: Burst Stimulation (Device)

结局指标

主要结局

Visual Analog Scale (VAS) Pain Diary Scores for Average Overall Pain

时间窗: Over 7 days after 3 months of treatment of burst or tonic stimulation

Differences for average daily overall pain using the Visual Analog Scale (VAS) pain diary between Burst and Tonic Stimulation. Visual Analog Scale (VAS) scores were averaged using a 7 day diary where the subject rates his/her pain on a horizontal line, from 0 mm to 100mm in length, anchored by word descriptors on each end (no pain to worst imaginable pain). A higher score indicates a higher level of pain.

次要结局

  • Percentage of Paresthesia Coverage(During in-office visit after 3 months of treatment while utilizing burst or tonic stimulation)
  • Number of Subjects With Response as Measured by Overall Daily Visual Analog Scale (VAS)(Over 7 days at baseline and after 3 months of treatment of burst or tonic stimulation)
  • Test for Superiority of Overall Daily Visual Analog Scale (VAS) Score With Burst Stimulation(Over 7 days after 3 months of treatment of burst or tonic stimulation)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验